Table 1 The expression of VEGF, MMP-9, EGF and FGF-2 as detected by LUMINEX
From: Argonaute 2 promotes myeloma angiogenesis via microRNA dysregulation
| Â | VEGF (pg/ml) | MMP-9 (pg/ml) | EGF (pg/ml) | FGF-2 (pg/ml) |
|---|---|---|---|---|
H929/Si-NC | 2132.33 ± 328.02 | 15.03 ± 0.80 | 48.80 ± 10.42 | 98.30 ± 16.56 |
H929/SiR-AGO2 | 194.67 ± 54.12 | 14.00 ± 1.65 | 49.62 ± 4.22 | 94.86 ± 7.90 |
OCI-MY5/pcDNA3 | 0.92 ± 0.29 | 12.22 ± 1.48 | 55.96 ± 6.77 | 81.84 ± 9.04 |
OCI-MY5/pcDNA3-AGO2 | 10.36 ± 1.32 | 13.49 ± 1.80 | 53.74 ± 9.45 | 77.91 ± 5.98 |
LP-1/Si-NC | 1858.00 ± 368.49 | 8.58 ± 0.85 | 147.34 ± 17.63 | 54.37 ± 9.14 |
LP-1/SiRNA-AGO2 | 748.56 ± 86.28 | 9.19 ± 0.85 | 146.77 ± 11.09 | 50.47 ± 7.19 |
U266/pcDNA3 | 164.97 ± 55.62 | 7.99 ± 1.40 | 177.94 ± 14.40 | 101.80 ± 13.62 |
U266/pcDNA3-AGO2 | 1522.00 ± 209.80 | 7.66 ± 1.27 | 173.05 ± 16.47 | 98.87 ± 14.38 |